icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
A Predictive Tool for Selecting HBeAg-Positive Chronic Hepatitis B Patients Who Have a High Probability of HBV DNA Suppression and HBeAg Seroconversion with Peginterferon Alfa-2a
 
 
  Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
 
H.L.-Y. Chan1, G.V. Papatheodoridis2, D. Messinger3, G. Bakalos4, P. Lampertico5 1Department of Medicine and Therapeutics, Institute of Digestive Disease and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; 2Department of Gastroenterology, Athens University Medical School, Laiko General Hospital, Athens, Greece; 3IST GmbH, Mannheim, Germany; 4F. Hoffmann-La Roche Ltd, Basel, Switzerland; 5AM & A Migliavacca Center for Liver Disease, 1st Gastroenterology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UniversitÓ degli Studi di Milano, Milan, Italy

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif